| [1] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志，2020，35(9)：833－854.
|
| [2] |
Wang S, Xu L, Jonas JB, et al. Dyslipidemia and eye diseases in the adult Chinese population: the Beijing eye study[J]. PLoS One, 2012, 7(3): e26871.
|
| [3] |
Chapman MJ, Ginsberg HN, Amarenco P, et al. Triglyceride－rich lipoproteins and high－density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management[J]. Eur Heart J, 2011, 32(11): 1345－1361.
|
| [4] |
Wang S, Bao X. Hyperlipidemia, blood lipid level, and the risk of glaucoma: a meta－analysis[J]. Invest Ophthalmol Vis Sci, 2019, 60(4): 1028－1043.
|
| [5] |
Kim YH, Jung SW, Nam GE, et al. High intraocular pressure is associated with cardiometabolic risk factors in South Korean men: Korean National Health and Nutrition Examination Survey, 2008—2010[J]. Eye (Lond), 2014, 28(6): 672－679.
|
| [6] |
中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华全科医师杂志，2017，16(1): 15－35.
|
| [7] |
Marcus MW, Müskens RP, Ramdas WD, et al. Cholesterol－lowering drugs and incident open－angle glaucoma: a population－based cohort study[J]. PLoS One, 2012, 7(1): e29724.
|
| [8] |
Pertl L, Mossböck G, Wedrich A, et al. Triglycerides and open angle glaucoma－a meta－analysis with meta－regression[J]. Sci Rep, 2017, 7(1): E7829.
|
| [9] |
Kim HA, Han K, Lee YA, et al. Differential association of metabolic risk factors with open angle glaucoma according to obesity in a korean population[J]. Sci Rep, 2016, 6: 38283.
|
| [10] |
Zhang Y, Zhang Q, Thomas R, et al. Association of hyper－triglyceridemia and incident glaucoma in a rural Chinese population: The Handan Eye Study[J]. Transl Vis Sci Technol, 2021, 10(8): 25.
|
| [11] |
Lee SH, Kim GA, Lee W, et al. Vascular and metabolic comorbidities in open－angle glaucoma with low and high－teen intraocular pressure: a cross－sectional study from South Korea[J]. Acta Ophthalmol, 2017, 95(7): e564－e574.
|
| [12] |
PavljaseviĉS, Asĉeriĉ M. Primary open－angle glaucoma and serum lipids[J]. Bosn J Basic Med Sci, 2009, 9(1): 85－88.
|
| [13] |
Ko F, Boland MV, Gupta P, et al. Diabetes, triglyceride levels, and other risk factors for glaucoma in the national health and nutrition examination survey 2005—2008[J]. Invest Ophthalmol Vis Sci, 2016, 1；57(4): 2152－2157.
|
| [14] |
Talwar N, Musch DC, Stein JD. Association of daily dosage and type of statin agent with risk of open－angle glaucoma[J]. JAMA Ophthalmol, 2017, 135(3): 263－267.
|
| [15] |
Kim MJ, Kim MJ, Kim HS, et al. Risk factors for open－angle glaucoma with normal baseline intraocular pressure in a young population: the Korea National Health and Nutrition Examination Survey[J]. Clin Exp Ophthalmol, 2014, 42(9): 825－832.
|
| [16] |
Lin HC, Chien CW, Hu CC, et al. Comparison of comorbid conditions between open－angle glaucoma patients and a control cohort: a case－control study[J]. Ophthalmology, 2010, 117(11): 2088－2095.
|
| [17] |
Newman－Casey PA, Talwar N, Nan B, et al. The relationship between components of metabolic syndrome and open－angle glaucoma[J]. Ophthalmology, 2011, 118(7): 1318－1326.
|
| [18] |
Xu M, Li S, Zhu J, et al. Plasma lipid levels and risk of primary open angle glaucoma: a genetic study using Mendelian randomization[J]. BMC Ophthalmol, 2020, 20(1): 390.
|
| [19] |
dos－Santos MG, Makk S, Berghold A, et al. Intraocular pressure difference in Goldmann applanation tonometry versus Perkins hand－held applanation tonometry in overweight patients[J]. Ophthalmology, 1998, 105(12): 2260－2263.
|
| [20] |
Kim M, Jeoung JW, Park KH, et al. Metabolic syndrome as a risk factor in normal－tension glaucoma[J]. Acta Ophthalmol, 2014, 92(8): e637－e643.
|
| [21] |
韩菲，殷玲，路国涛，等. 高密度脂蛋白与代谢综合征的关系[J]. 医学综述，2020，26(2)：356－360，365.
|
| [22] |
Hwang IC, Lee YJ, Bae JH. A meta－analysis of glaucoma risk in hyperlipidemic individuals: a critical problem in design[J]. Invest Ophthalmol Vis Sci, 2016, 57(14): 6339－6340.
|
| [23] |
McCann P, Hogg RE, Fallis R, et al. The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta－analysis[J]. Invest Ophthalmol Vis Sci, 2016, 57(6): 2729－2748.
|
| [24] |
Kim MJ, Park KH, Kim CY, et al. The distribution of intraocular pressure and associated systemic factors in a Korean population: the Korea National Health and Nutrition Examination Survey[J]. Acta Ophthalmol, 2014, 92(7): e507－e513.
|
| [25] |
Zheng Y ，Cheung CY, Wong TY, et al. Influence of height, weight, and body mass index on optic disc parameters[J]. Invest Ophthalmol Vis Sci, 2010, 51(6): 2998－3002.
|
| [26] |
Xu L, Wang YX, Wang S, et al. Neuroretinal rim area and body mass index[J]. PLoS One, 2012, 7(1): e30104.
|
| [27] |
McGwin G, McNeal S, Owsley C, et al. Statins and other cholesterol－lowering medications and the presence of glaucoma[J]. Arch Ophthalmol, 2004, 122(6): 822－826.
|
| [28] |
Stein JD, Newman－Casey PA, Talwar N, et al. The relationship between statin use and open－angle glaucoma[J]. Ophthalmology, 2012, 119(10): 2074－2081.
|
| [29] |
Khawaja AP, Chan MP, Broadway DC, et al. Systemic medication and intraocular pressure in a British population: the EPIC－Norfolk Eye Study[J]. Ophthalmology, 2014, 121(8): 1501－1507.
|
| [30] |
Chen HY, Hsu SY, Chang YC, et al. Association between statin use and open－angle glaucoma in hyperlipidemia patients: A Taiwanese Population－based Case－control Study[J]. Medicine (Baltimore), 2015, 94(45): e2018.
|
| [31] |
Song J, Deng PF, Stinnett SS, et al. Effects of cholesterol－lowering statins on the aqueous humor outflow pathway[J]. Invest Ophthalmol Vis Sci, 2005, 46(7): 2424－2432.
|
| [32] |
Jia LY, Gong B, Pang CP, et al. Correction of the disease phenotype of myocilin－causing glaucoma by a natural osmolyte[J]. Invest Ophthalmol Vis Sci, 2009, 50(8): 3743－3749.
|
| [33] |
乐世俊，王文晓，陶慧娟，等. 肠道菌群－TMA－TMAO代谢途径与心血管疾病的研究进展[J]. 中华心血管病杂志，2020，48(2)：159－163.
|
| [34] |
Skrzypecki J, Izdebska J, Kamińska A, et al. Glaucoma patients have an increased level of trimethylamine, a toxic product of gut bacteria, in the aqueous humor: a pilot study[J]. Int Ophthalmol, 2021, 41(1): 341－347.
|
| [35] |
Yoo W, Zieba JK, Foegeding NJ, et al. High－fat diet－induced colonocyte dysfunction escalates microbiota－derived trimethylamine N－oxide[J]. Science, 2021, 373(6556): 813－818.
|
| [36] |
Bulpitt CJ, Hodes C, Everitt MG. Intraocular pressure and systemic blood pressure in the elderly[J]. Br J Ophthalmol, 1975, 59(12): 717－720.
|
| [37] |
Shiose Y. The aging effect on intraocular pressure in an apparently normal population[J]. Arch Ophthalmol, 1984, 102(6): 883－887.
|
| [38] |
Fu J, Bonder MJ, Cenit MC, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids[J]. Circ Res, 2015, 117(9): 817－24.
|
| [39] |
Mancia G, Bousquet P, Elghozi JL, et al. The sympathetic nervous system and the metabolic syndrome[J]. J Hypertens, 2007, 25(5): 909－920.
|
| [40] |
MacDougald OA, Burant CF. Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter[J]. Proc Natl Acad Sci USA, 2005, 102(31): 10759－10760.
|
| [41] |
常田，杨雪丽，王鹏旭，等. 肠道菌群与糖尿病眼部并发症关系的研究进展[J]. 中华糖尿病杂志，2020，12(7)：551－554.
|
| [42] |
Andriessen EM, Wilson AM, Mawambo G, et al. Gut microbiota influences pathological angiogenesis in obesity－driven choroidal neovascularization[J]. EMBO Mol Med, 2016, 8(12): 1366－1379.
|
| [43] |
Deschênes MC, Descovich D, Moreau M, et al. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer[J]. Invest Ophthalmol Vis Sci, 2010, 51(5): 2587－2600.
|
| [44] |
Rowan S, Taylor A. Gut microbiota modify risk for dietary glycemia－induced age－related macular degeneration[J]. Gut Microbes, 2018, 9(5): 452－457.
|
| [45] |
Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive－leptin concentrations in normal－weight and obese humans[J]. N Engl J Med. 1996, 334(5): 292－295.
|
| [46] |
López－Riquelme N, Villalba C, Tormo C, et al. Endothelin－1 levels and biomarkers of oxidative stress in glaucoma patients[J]. Int Ophthalmol, 2015, 35(4): 527－532.
|
| [47] |
Wang SY, Singh K, Lin SC. Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population－based sample of the United States[J]. Eye (Lond), 2013, 27(4): 487－494.
|
| [48] |
Zhang F, Wang S, Signore AP, et al. Neuroprotective effects of leptin against ischemic injury induced by oxygen－glucose deprivation and transient cerebral ischemia[J]. Stroke, 2007, 38(8): 2329－2336.
|
| [49] |
Saccà SC, Gandolfi S, Bagnis A, et al. The Outflow Pathway: A Tissue With Morphological and Functional Unity[J]. J Cell Physiol, 2016, 231(9): 1876－93.
|
| [50] |
田佳鑫，曹凯，石砚，等. 原发性开角型青光眼全身危险因素及眼体同治的系统回顾和Meta分析[J]. 中华眼科医学杂志(电子版)，2019，9(5)：281－291.
|
| [51] |
Kim HJ, Min KB, Min JY. Neuropeptide Y gene－by－psychosocial stress interaction effect is associated with obesity in a Korean population[J]. Psychoneuroendocrinology, 2016, 69: 10－15.
|
| [52] |
Santos－Carvalho A, Elvas F, Alvaro AR, et al. Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate[J]. Cell Death Dis, 2013, 4(5): e636.
|
| [53] |
Kishida K, Naka KI. Amino acids and the spikes from the retinal ganglion cells[J]. Science, 1967, 156(3775): 648－650.
|
| [54] |
Cao X, Guo Y, Wang Y, et al. Effects of high－fat diet and Apoe deficiency on retinal structure and function in mice[J]. Sci Rep, 2020, 10(1): 18601.
|
| [55] |
Ramdas WD, Schouten JSAG, Webers CAB. The effect of vitamins on glaucoma: a systematic review and meta－analysis[J]. Nutrients, 2018, 10(3): 359.
|
| [56] |
Pang R, Feng S, Cao K, et al. Association of serum retinol concentration with normal－tension glaucoma[J]. Eye (Lond), 2022, 36(9): 1820－1825.
|